Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
Community GuideSubcutaneous in guideDaily
Third-party educational bioregulator schedule
100 mcg daily in weeks 1-2, 150 mcg in weeks 3-4, 200 mcg in weeks 5-8 and 250-300 mcg in weeks 9-12
No adequate controlled human testagen programme validates the quantity, duration or proposed route. It is displayed as a low-confidence retail convention.
View sourceEvidence summary
A peptide bioregulator promoted for testicular and reproductive claims. Adequate controlled human evidence is not available to define a protocol.
Protocol basis
The evidence search did not yield a reproducible, matched human protocol, so none is inferred from marketing material.
What remains uncertain
Human pharmacology, reproductive effects, interactions, long-term safety and controlled efficacy are unknown.
Warnings and contraindications
No adequate controlled human regimen was identified in major indexed literature.
Hormonal and fertility claims need objective clinical monitoring.
Retail schedules do not establish identity, efficacy or safety.